Trial intelligence / Profile preview

House dust mite SLIT for primary prevention of atopy and asthma (6-8 year follow-up)

NCT03763630Phase 2Completed

Sponsor
University of Southampton
Start
Sep 2017
Primary completion
Dec 2018
Countries
1
01

Overview

A Phase 2 trial of House dust mite allergen extract in asthma, Atopy, sponsored by University of Southampton. Started Sep 2017; status: completed.

02

Drugs

House dust mite allergen extract
03

Conditions

asthmaAtopy

Beyond the preview

Go deeper on NCT03763630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03763630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call